English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 28 April 2020, 19:00 HKT/SGT
Share:
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes

SYDNEY, Apr 28, 2020 - (ACN Newswire) - Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates.




A Novotech Client COVID-19 trial was just approved in under 9 days in South Korea.

The South Korean Ministry of Food and Drug Safety (MFDS) has announced "GO-expedite" program where they are expediting the review process for COVID-19 treatment and vaccine trials with specific timelines.

Other countries are also fast-tracking COVID-19 trial reviews including:
-- India: review/approval in 10 working days
-- Thailand: review/approval in 15 working days
-- Malaysia: review/approval in 20 working days

Novotech Executive Director, Asia Operations, Dr. Yooni Kim said she was pleased to see such a rapid response in the region to support vital research.

"We are seeing an increase in demand from biotechnology sponsors for studies in the Asia-Pacific region because of the speed and quality available here. This expedited review process will further support the race for COVID-19 treatments."

For the latest updates on the Asia-Pacific clinical trial landscape see our Data Bulletins (updated weekly).
View and download COVID-19 Data Bulletins here: https://novotech-cro.com/covid-19-notice

About Novotech - https://novotech-cro.com

Novotech is internationally recognized as the leading regional full-service contract research organization (CRO) in Asia-Pacific. Novotech has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotechnology companies. Novotech was established in 1996, with offices in 11 locations across the region, and site partnerships with major health institutions.

Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management.

Novotech obtained the ISO 27001 certification which is the best-known standard in the ISO family providing requirements for an Information Security Management System. Together with the ISO 9001 Quality Management system, Novotech aims at the highest IT security and quality standards for patients and biotechnology companies.

For RFP enquiries: Please fill out the form available at https://novotech-cro.com/talk-to-an-expert

Media contact:
David James
[email protected]
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427


Topic: Press release summary
Sectors: BioTech, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Five Advisors With Focus Partner Firm Escala Partners Named to Australia's Top 100 Financial Advisers 2020 List  
July 3, 2020 11:00 HKT/SGT
NEC and JAMSTEC Develop AI-based System for Measuring Microplastics in the Ocean  
July 3, 2020 10:30 HKT/SGT
Gynesys Best Home Security Urges Businesses to Work with African-American Owned Commercial Security Firms in the Aftermath of CPI Security CEO's Remarks; Prepared to Work with Carolina Panthers, Charlotte Hornets to Replace CPI as Major Sponsor  
July 2, 2020 15:00 HKT/SGT
Singapore's Leading B2B Tech Event Stack Rescheduled to 2021  
July 2, 2020 10:52 HKT/SGT
MOG Recorded a YOY Earnings Growth for the year ended 31 March 2020 by leveraging its extensive retail network and strong brand recognition to capture new market opportunities  
July 2, 2020 08:25 HKT/SGT
Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of Dorzagliatin  
July 1, 2020 19:00 HKT/SGT
Black Wealth Matters Welcomes SEC Internal Investigation Into Racist Attack on Solomon Ali; Demands Transparency and Accountability  
July 1, 2020 15:00 HKT/SGT
Fujitsu Revamps Corporate Philosophy 'FUJITSU Way' to Achieve Our Purpose  
July 1, 2020 13:22 HKT/SGT
Remap-Cap to Partner With Eisai on Innovative Trial to Combat COVID  
July 1, 2020 13:02 HKT/SGT
Toyota Launches New Acceleration Suppression System  
July 1, 2020 12:48 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575